SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-079709
Filing Date
2023-07-10
Accepted
2023-07-10 17:19:09
Documents
16
Period of Report
2023-05-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2320984d1_8k.htm   iXBRL 8-K 29582
2 EXHIBIT 10.65 tm2320984d1_ex10-65.htm EX-10.65 10743
3 GRAPHIC logo.jpg GRAPHIC 3795
4 GRAPHIC signature1.jpg GRAPHIC 3501
5 GRAPHIC signature2.jpg GRAPHIC 3684
  Complete submission text file 0001104659-23-079709.txt   232698

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rgrx-20230509.xsd EX-101.SCH 3283
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgrx-20230509_lab.xml EX-101.LAB 34240
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgrx-20230509_pre.xml EX-101.PRE 22359
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2320984d1_8k_htm.xml XML 3204
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15070 | Film No.: 231080593
SIC: 2834 Pharmaceutical Preparations